SCHEMBL23267809

SCHEMBL23267809

CO/C(C)=C(/C)c1cc(-c2ccccc2)c2cc([Si](C)(C)C)ccc2n1

nearest known ligand 0.40

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ AURKA O14965 1/20 0.39
▸ AURKB Q96GD4 1/20 0.39
▸ ACACA Q13085 3/20 0.39
▸ PTGFR P43088 2/20 0.37
▸ KDM4E B2RXH2 3/20 0.37
▸ ALDH1A1 P00352 3/20 0.37
▸ LMNA P02545 2/20 0.36
▸ MAPT P10636 2/20 0.36
▸ NPSR1 Q6W5P4 2/20 0.36
▸ MEN1 O00255 1/20 0.36
▸ RECQL P46063 1/20 0.36
▸ KMT2A Q03164 1/20 0.36
▸ GRM2 Q14416 2/20 0.35
▸ NT5E P21589 1/20 0.34
▸ MAPK1 P28482 1/20 0.34
▸ ESR1 P03372 1/20 0.34
▸ ESR2 Q92731 1/20 0.34
▸ HSP90AA1 P07900 1/20 0.34
▸ HPGD P15428 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23268092 0.83 ALDH1A1 (0.36) AURKAAURKBACACAPTGFRKDM4E
SCHEMBL23268389 0.82 ALDH1A1 (0.39) AURKAAURKBPTGFRKDM4EALDH1A1
SCHEMBL23267808 0.82 PTGFR (0.35) AURKAAURKBPTGFRKDM4EALDH1A1
SCHEMBL23267807 0.81 ALDH1A1 (0.38) AURKAAURKBPTGFRKDM4EALDH1A1
SCHEMBL23268157 0.79 KDM4E (0.37) KDM4EALDH1A1
SCHEMBL23241891 0.77 ALDH1A1 (0.57) AURKAAURKBACACAKDM4EALDH1A1
SCHEMBL23267810 0.76 ALDH1A1 (0.46) AURKAAURKBPTGFRKDM4EALDH1A1
SCHEMBL23241888 0.71 ALDH1A1 (0.55) AURKAAURKBACACAPTGFRKDM4E
SCHEMBL28313467 0.69 ALDH1A1 (0.52) KDM4EALDH1A1LMNAMAPTNPSR1
SCHEMBL28554215 0.68 DHODH (0.57) KDM4EALDH1A1GRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210115077-A1 Organometallic compound, organic light-emitting device including the same, and diagnosing composition including the organometallic compound SAMSUNG ELECTRONICS CO., LTD. (KR) 2021-04-22 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210115077-A1 Organometallic compound, organic light-emitting device including the same, and diagnosing composition including the organometallic compound L1CAM, MSL1, NOM1 AURKA 1277/4885AURKB 1476/4885ACACA 2517/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback